E. Q. Roldàn

Insertion of a short human immunodeficiency virus (HIV)‐2 gp36 sequence into an HIV‐1 p24 recombinant protein results in a polypeptide with potent and TCRBV‐restricted T cell triggering activity

L. Imberti, A. Albertini, D. Primi, 1995, European journal of immunology.

Different TCRBV genes generate biased patterns of V-D-J diversity in human T cells

Alberto Albertini, L. Imberti, A. Albertini, 2004, Immunogenetics.

CONCISE COMMUNICATION Liver Damage and Kinetics of Hepatitis C Virus and Human Immunodeficiency Virus Replication during the Early Phases of Combination Antiretroviral Treatment

G. Carosi, M. Puoti, A. Chiodera, 2022 .

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, BMC Public Health.

Detection of skewed T-cell receptor V-β gene usage in the peripheral blood of patients with multiple sclerosis

L. Amaducci, L. Massacesi, D. Gestri, 1998, Journal of Neuroimmunology.

Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature

F. Facchetti, F. Castelli, I. Izzo, 2018, Mediterranean journal of hematology and infectious diseases.

Trends in Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections: Effect of the MRSA “Search and Isolate” Strategy in a Hospital in Italy with Hyperendemic MRSA

C. Tinelli, G. Carosi, A. Pan, 2005, Infection Control & Hospital Epidemiology.

Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study

G. Guaraldi, A. Malagoli, G. di Perri, 2017, The Journal of antimicrobial chemotherapy.

An Outbreak of Serratia marcescens Bloodstream Infections Associated With Misuse of Drug Vials in a Surgical Ward

A. Pan, E. Roldàn, L. Soavi, 2006, Infection Control & Hospital Epidemiology.

Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV

A. d’Arminio Monforte, A. Antinori, G. Marchetti, 2021, BMC Infectious Diseases.

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

F. Montagnini, M. Giacomini, G. Innocenti, 2020, Journal of Translational Medicine.

First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, A. Lazzarin, 2018, HIV medicine.

Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, The Journal of antimicrobial chemotherapy.

Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients

A. Antinori, C. Mussini, J. Fehr, 2016 .